Rance Fujiwara

Assistant Professor

University of Texas Southwestern Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Year:

2026

Objective: To examine national trends in the hospitalization of patients with malignant otitis externa (MOE), with a specific focus on the proportion of admissions to teaching versus nonteaching hospitals. Study design: Retrospective cohort study using a national database (National Inpatient Sample). Setting: United States inpatient hospitalizations from 1998 to 2021. Patients: Adult patients (18 y or older) admitted with a primary diagnosis of malignant otitis externa. Interventions: Not applicable. Main outcome measures: Admission to a teaching versus a nonteaching hospital. Multivariate logistic regression identified demographic and clinical factors associated with hospital-type admission. Temporal trends were analyzed over the 24-year period. Results: A total of 16,540 MOE admissions were identified. Admissions to teaching hospitals increased by 290.6% from 1998 to 2021, while nonteaching hospital admissions decreased by 55.8%. Teaching hospitals accounted for 57.7% of all MOE admissions and treated patients with higher comorbidity burdens. On multivariate analysis, factors independently associated with teaching hospital admission included Black race (OR: 2.56, P <0.001), Hispanic ethnicity (OR: 1.54, P =0.004), Medicaid insurance (OR: 1.60, P =0.001), diabetes with complications (OR: 1.86, P <0.001), HIV/AIDS (OR: 5.08, P =0.01), and metastatic cancer (OR: 8.66, P =0.02). Each successive year increased the odds of teaching hospital admission by 8% (OR: 1.08, P <0.001). Conclusions: MOE admissions in the U.S. have shifted significantly toward teaching hospitals over the past 2 decades, with these centers treating patients with greater medical complexity and immunocompromising conditions. These findings underscore the increasing centralization of MOE care at academic centers, raising important considerations about health care access, equity, and resource allocation. Level of Evidence: Level III.

Year:

2026

This study aimed to characterize the rate of secretory tumors and the rate and types of genetic variations identified in patients diagnosed with head and neck (HN) paragangliomas. A retrospective case review. Tertiary referral center. About 74 patients with HN paragangliomas treated with gamma knife radiosurgery. Genetics testing via the Ambry Genetics Hereditary Paraganglioma and Pheochromocytoma Panel, and 24-hour urine metanephrine and catecholamine levels, were obtained. Pathogenic and likely pathogenic variations were tabulated. Levels of 24-hour urinary epinenephrine, norepinephrine, metanephrine, normetanephrine, and dopamine were recorded and correlated with rates of genetic variations. Of 74 patients, 46 (62.2%) and 38 (51.4%) underwent laboratory and genetics testing, respectively; 29 (39.2%) completed both. Nine (19.6%) had abnormally elevated 24-hour urine metanephrine/catecholamine, of whom eight (88.9%) had elevated normetanephrine levels. Pathogenic/likely pathogenic variations were found in 15/38 (39.5%) patients. Among those with both genetics and laboratory testing, 4/12 (33.3%) with a pathogenic variation had evidence of secretory tumors, compared with 1/17 (5.9%) of those without a variation. Conversely, 80% (4/5) of patients with abnormally elevated metanephrine or catecholamine studies had a pathogenic genetic variation, compared with 33.3% (8/24) with normal laboratory results. This is a single-institution cohort with HN paragangliomas who underwent genetic testing and urine catecholamine and metanephrine studies. We demonstrate that a large fraction of patients presenting with HN paragangliomas have pathogenic genetic variations and secreting tumors. Genetic testing and counseling, and laboratory studies, should thus be performed in patients diagnosed with HN paragangliomas.

Year:

2026

Year:

2026

Year:

2025

Hypothesis The objective of this study is to obtain comprehensive morphometric measurements of the incomplete partition type II (IP-II) cochlea to provide a better understanding of intracochlear anatomy and important considerations for electrode selection and insertion. Background IP-II is the most common bony inner ear malformation that often requires cochlear implantation. Currently, there is significant controversy on electrode selection due to a lack of research that can provide reliable, high-resolution measurements. Methods Three-dimensional reconstructions of the cochlea were made from hematoxylin and eosin–stained slides from 11 archival human temporal bones from 8 adult IP-II patients (one paired) and 2 fetuses. Detailed measurements of the angular and linear length of the spiral ganglion neurons and cochlear duct at the modiolar and lateral wall of the scala tympani as well as cross-sectional areas and vertical height measurements of the scala tympani at 90-degree intervals were measured. Results The spiral ganglia neurons terminated at 540.5 ± 45.4 degrees, which corresponded to the beginning of the interscalar septal defect. The corresponding Rosenthal's canal length was 12.75 ± 0.82 mm, and the lateral wall length was 23.95 ± 1.04. The average cochlear duct length was 32.44 mm ± 1.58 mm, corresponding to an average angular distance of 951.6 ± 80 degrees. The modiolar height demonstrated less variation within the scala tympani but was significantly smaller at 0 and 90 degrees compared with the normal cochlea. The lateral wall height was also significantly smaller at 0, 180, and 540 degrees. There was a drastic decrease in lateral wall height at 540 degrees to 0.4 mm, which is smaller than the apical dimension of many electrodes. Conclusion This is the first study to provide detailed morphometric measurements of the IP-II cochlea including spiral ganglion neuron length and scala tympani height. These measurements directly relate to electrode selection for cochlear implantation.

Year:

2025

Objective To understand trends in Medicare reimbursement for neurotology procedures from 2000 through 2024. Methods The Physician Fee Schedule (PFS) Look-Up Tool from the Center for Medicare and Medicaid Services was used to assess reimbursement data for relevant otologic/neurotologic Current Procedural Terminology (CPT) codes from 2000 to 2024. All monetary data were adjusted to 2024 U.S. dollars using the U.S. Bureau of Labor Statistics Consumer Price Index. Percent changes in reimbursement were calculated. Results The average nominal value of reimbursement for all procedures increased by 11.20% from 2000 to 2024. However, after adjusting for inflation, the average change in Medicare reimbursement was −33.52%. The greatest decrease was in CPT code 69714, which saw a 2024 U.S. dollar −66.43% change. The greatest increase was in CPT code 61798, which saw a 43.43% change. An increase in reimbursement for all CPT codes occurred only in 2024. This increase was associated with the calendar year 2024 PFS final rule, which came into effect on March 9 and increased the PFS conversion factor from $32.7442 to $33.2875. From 2000 to 2024, the PFS conversion factor decreased from $36.6137 to $33.2875. Conclusion From 2000 to 2023, Medicare reimbursements for otologic and neurotologic procedures decreased after adjusting for inflation. The only year with an increase in reimbursement was 2024, which saw an increase to the PFS conversion factor. These trends highlight the need for greater awareness of, and agreement on, neurotology reimbursement models among surgeons, policy makers, and facility administrators.

Year:

2025

Objective To characterize inpatient costs and complication rates in sporadic and neurofibromatosis type 2 (NF2) patients undergoing resection of vestibular schwannoma (VS). Design Cross-sectional analysis. Setting National Inpatient Sample, 1998–2021. Participants A total of 52,623 inpatient admissions after VS resection. Interventions Resection of VS. Main Outcome(s) and Measure(s) Patient- and hospital-level demographics of admissions following resection of VS, as well as the frequency of postoperative medical and surgical complications, were tabulated. We evaluated the average cost of admission and compared these outcomes between sporadic and NF2 patients. Multivariate analysis was performed to determine whether NF2 admissions had increased costs and lengths of stay. Results A total of 51,459 and 1,164 resections were recorded for sporadic and NF2 patients, respectively. Patients with NF2 were younger (mean age 35.3 vs. 51.1 years) and more likely insured by Medicaid (12.8% vs. 5.4%). The average cost for NF2 admissions was $49,141 (95% CI, 42,527–55,754), relative to sporadic tumors at $38,204 (95% CI, 36,408–40,000). NF2 patients had increased rates of surgical complications, including facial nerve dysfunction (31.7% vs. 17.3%), dysphagia (8.8% vs. 2.8%), aspiration pneumonia (3.4% vs. 0.6%), and sepsis (1.8% vs. 0.4%), which were associated with increased hospital costs. NF2 was not independently associated with increased inpatient hospital costs after controlling for patient factors and complications ($3,977 [95% CI, −$111 to 8,066], p = 0.06). Conclusions Relative to sporadic VS admissions, resections in NF2 patients are associated with significantly increased hospital costs, primarily due to increased rates of postoperative surgical, central nervous system–related, and medical complications.

Year:

2025

Objective To examine temporal trends in postoperative surgical and medical complications after vestibular schwannoma (VS) resections, and to describe changes in inpatient hospitalization costs. Study Design Cross-sectional analysis. Setting National Inpatient Sample, 1998–2021. Participants 50,991 admissions. Interventions VS resection. Main Outcome Measure(s) Surgical and medical complications after VS resection were recorded annually and trended over time. The annual average cost of inpatient hospitalization (in inflation adjusted 2024 US dollars) and length of stay were also documented for each year. Multivariate analysis was performed to determine whether subsequent calendar years were associated with changes in costs. Results From 1998 to 2021, the annual average number of VS resections decreased by 32.7% from 3,813 to 2,557. Rates of surgical and medical complications increased from 18.2 to 34.2% ( b = 0.73 [95% CI, 0.53–0.93], p < 0.001), and from 4.3 to 7.6% ( b = 0.17 [95% CI, 0.11–0.22], p < 0.001), respectively. The number of comorbidities among surgical patients increased over time, and rates of complications increased among patients with higher comorbidity scores, with 54.0% of those with ≥4 comorbidities experience a complication, compared with 28.1% of those with no comorbidities. The mean inpatient cost per admission increased from $30,922 to $45,973, which was statistically significant on multivariate regression ( b = $412 [95% CI, 208–615], p < 0.001), despite a decrease in average inpatient stay from 5.4 (SE 0.5) to 4.5 (SE 0.3) days. Conclusions As the number of VS operations has decreased, the percentage with postoperative complications has increased, likely due to changes in patient selection as well as increasing comorbidities in operative cases. Healthcare expenditures for postoperative admissions have increased significantly over the last two decades, resulting in a roughly $15,000 increase in mean inflation-adjusted inpatient costs per postoperative admission.

Year:

2025

Cochlear implants (CIs) have demonstrated a clear functional benefit in children with severe-to-profound sensorineural hearing loss (SNHL) and thus have gained wide acceptance for treating deafness in the pediatric population. When evaluating young children for cochlear implantation, there are unique considerations beyond the standard issues addressed during surgery in adults. Because of advances in genetic testing, imaging resolution, CI technology, post-implant rehabilitation, and other factors, issues related to CI surgery in children continue to evolve. Such factors have led to changes in candidacy guidelines, vaccine requirements, and lowering of age requirement for surgery. In addition, differences in the anatomy and physiology of infants require special attention to ensure safety when operating on young children. This review summarizes these issues and provides guidance for surgeons treating children with SNHL.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (2)

Akira Ishiyama

Professor

University of California, Los Angeles

UNITED STATES
View details

Brandon Isaacson

Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details